Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube Follow us on Vimeo
Early Phase Clinical Research
Frequently Asked Questions (FAQ)

Get the news first! Sign-up to receive e-mail updates on new studies that are enrolling volunteers.

First Name:  
Last Name:  


5355 Medpace Way
Cincinnati, Ohio 45227
Email us Download our contact info straight to your phone.

Do you know of someone else who may be interested in participating in a trial? When your friend completes their first research study with Medpace, you will receive $100. Download the Medpace Refer a Friend Card.

We are currently looking for patients with Osteoarthritis and Rheumatoid Arthritis. Learn more about enrolling in arthritis studies here or refer a friend and earn $100.

Stay Connected

"Like" us on Facebook to stay up-to-date on new studies that are enrolling.

Like Medpace on Facebook to stay up-to-date on enrolling studies

1. How do I get started?

Participants must volunteer to take part in a study. Medpace Clinical Pharmacology determines your eligibility for current or future studies based on your medical history and the answers you provide to our study participant questionnaire. Your answers are kept completely private and are not shared with anyone else.

After you volunteer and you are deemed eligible for a specific study, the next step is to schedule a screening appointment with a doctor or nurse practitioner. You will go through the informed consent process, receive a complete medical examination, and, depending upon the study, undergo blood/urine testing to confirm you are in good health before you enroll.

If you do not qualify for a specific study right away, we will keep your name in our confidential database, and contact you when we have a study that is a good match for you.

To volunteer, call (513) 366-3222 or (859) 341-9800.

2. Will I be hurt by Phase I medical research?

Because the risks involved in each study are different, it is important that you carefully read the risk section of the consent form. Ask the staff questions you may have about your safety in the study in which you are interested. No guarantees or promises can be made about the safety of any drug being tested.

3. Why must I stay overnight?

Staying overnight in the Medpace Clinical Pharmacology unit (CPU) provides the most controlled environment for a Phase I or Phase IIa study. This includes the ability to standardize meals, activities, medication dosing, taking blood/urine samples, special testing, and monitoring for adverse events. Most of the time, you will stay only a few days or more. However, there may be some studies that last longer than a week.

In order to make your stay as comfortable as possible, the CPU features:

  • Recreation rooms outfitted with widescreen televisions, board games, and other activities
  • Personal DVD players and library of DVDs
  • Desktop computers
  • Wireless technology and computer hook-ups for use with the volunteers’ laptop computers
  • Video games (Xbox 360®)
  • A well-lit, secure outdoor courtyard (weather permitting)
  • Catered meals

4. Are visitors allowed for stays requiring more than a couple days?

Unfortunately, the CPU does not have a visiting area, so during your stay your contact with friends and family is limited to e-mail and/or phone.

5. Am I allowed to quit at any time?

As you will learn during the informed consent process, volunteers are allowed to withdraw their consent for study participation at any time. You may also ask to have your name removed from our volunteer database and we will stop contacting you for any future potential study participation. We may, however, ask you to complete a volunteer satisfaction survey detailing why you stopped in order to help us improve our studies and program for future participants. Any information you provide is confidential and greatly appreciated.

6. How can my family contact me in case of an emergency?

Emergency phone numbers are provided when the study begins, however, regular incoming calls may be limited if procedures and/or testing are in progress.